Jeffrey Scott Riley - Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jeffrey Scott Riley - trading volume in the past year for Gain Therapeutics, Inc.

Holdings reported by Jeffrey Scott Riley for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 30,000 $116 K $3.86 Mar 28, 2024 Direct
Stock Option (right to buy) 15,000 $87.9 K $5.86 Jun 24, 2024 Direct Common Stock

Transactions reported by Jeffrey Scott Riley for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership